NCT03690063

Brief Summary

Historically, the database on the HIV was organized within the framework of the medico-economic file of the human immunodeficiency (DMI-2), introduced jointly by the Direction of Hospitals (Mission AIDS) and the INSERM at the end of the 80s. Today this database is fed via the computerized medical record NADIS. Most part of the research works on the theme of the HIV take support on this database (DAD, EuroAIDS, Neuradapt).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 1996

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1996

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 1996

Completed
22.7 years until next milestone

First Submitted

Initial submission to the registry

September 17, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 1, 2018

Completed
6.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

October 1, 2018

Status Verified

September 1, 2018

Enrollment Period

Same day

First QC Date

September 17, 2018

Last Update Submit

September 27, 2018

Conditions

Human Immunodeficiency Virus

Outcome Measures

Primary Outcomes (1)

  • change of the clinico-biological signs of the patients

    change of the clinico-biological values form the start of the study, mesured every year, to the end of the study

    Each Year during 50 years

Secondary Outcomes (1)

  • number of the various type of adverse events related by type of treatments

    Each Year during 50 years

Other Outcomes (1)

  • number of the various type of co-morbidity

    Each Year during 50 years

Interventions

Follow upOTHER

Follow up of treatment, behavior, co-morbidity

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients HIV innocents of any treatment and recently infected

You may qualify if:

  • Enrol consecutive patients with a scheduled visit in the outpatient clinic (regardless of CD4 cell count and ART status).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nice

Nice, France

RECRUITING

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Central Study Contacts

Christian PRADIER, Pr

CONTACT

pradier.c@chu-nice.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 17, 2018

First Posted

October 1, 2018

Study Start

January 1, 1996

Primary Completion

January 1, 1996

Study Completion

December 31, 2024

Last Updated

October 1, 2018

Record last verified: 2018-09

Locations

FR(1)